Literature DB >> 16341710

Equal proportions of affected cells in muscle and blood of a mosaic carrier of facioscapulohumeral muscular dystrophy.

Maria Manuela O Tonini1, Richard J L F Lemmers, Rita C M Pavanello, Antonia M P Cerqueira, Rune R Frants, Silvere M van der Maarel, Mayana Zatz.   

Abstract

Autosomal dominant facioscapulohumeral muscular dystrophy (FSHD) is associated with contractions of D4Z4 repeat on 4q35. It displays a remarkable inter- and intra-familial clinical variability ranging from severe phenotype to asymptomatic carriers. Mosaicism for the contracted FSHD-sized allele is a recurrent finding, but only DNA from lymphocytes had been studied. It is currently not known if mosaicism is unequally distributed between different tissues and if muscle is relatively spared for the presence of the disease allele in mosaic asymptomatic carriers of a disease allele. Here we compare DNA extracted from peripheral blood lymphocytes (PBL), fibroblasts and muscle from a mosaic asymptomatic female carrier and mother of a FSHD patient. PFGE analysis showed a complex allelic segregation: two independent mitotic rearrangement episodes occurred, resulting in mosaicism for a contracted D4Z4 repeat on 4q35 in the mother and mosaicism for an expanded D4Z4 repeat on 10q26 in the affected daughter. The results show that the proportion of mosaicism in PBL and muscle were comparable, while in fibroblasts there was some variation in the mosaicism, which might be caused by culturing artefacts. This finding supports the hypothesis that a mitotic contraction of D4Z4 is an early embryonic event and indicates that the degree of mosaicism in PBL is representative for that of muscle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341710     DOI: 10.1007/s00439-005-0100-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

1.  De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.

Authors:  S M van der Maarel; G Deidda; R J Lemmers; P G van Overveld; M van der Wielen; J E Hewitt; L Sandkuijl; B Bakker; G J van Ommen; G W Padberg; R R Frants
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.

Authors:  Michel van Geel; Morag C Dickson; Amy F Beck; Daniel J Bolland; Rune R Frants; Silvère M van der Maarel; Pieter J de Jong; Jane E Hewitt
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

3.  Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis.

Authors:  P de Kievit; M van Geel; M J van der Wielen; E Bakker; G W Padberg; R R Frants; S M van der Maarel
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

4.  Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Petra G M Van Overveld; Lodewijk A Sandkuijl; Harry Vrieling; George W Padberg; Rune R Frants; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2004-05-20       Impact factor: 11.025

5.  Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.

Authors:  Richard J F L Lemmers; Mariëlle Wohlgemuth; Rune R Frants; George W Padberg; Eva Morava; Silvere M van der Maarel
Journal:  Am J Hum Genet       Date:  2004-10-04       Impact factor: 11.025

6.  Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy.

Authors:  Borian T Buzhov; Richard J L F Lemmers; Ivailo Tournev; Michiel J R van der Wielen; Boriana Ishpekova; Radoslav Petkov; Julia Petrova; Rune R Frants; George W Padberg; Silvère M van der Maarel
Journal:  Neuromuscul Disord       Date:  2005-07       Impact factor: 4.296

7.  Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD).

Authors:  M Upadhyaya; J Maynard; M Osborn; P Jardine; P S Harper; P Lunt
Journal:  Muscle Nerve Suppl       Date:  1995

8.  Facioscapulohumeral muscular dystrophy in the Dutch population.

Authors:  G W Padberg; R R Frants; O F Brouwer; C Wijmenga; E Bakker; L A Sandkuijl
Journal:  Muscle Nerve Suppl       Date:  1995

9.  Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis.

Authors:  J Köhler; B Rupilius; M Otto; K Bathke; M C Koch
Journal:  Hum Genet       Date:  1996-10       Impact factor: 4.132

10.  Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy.

Authors:  M Funakoshi; K Goto; K Arahata
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  3 in total

1.  Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD.

Authors:  Yvonne D Krom; Julie Dumonceaux; Kamel Mamchaoui; Bianca den Hamer; Virginie Mariot; Elisa Negroni; Linda N Geng; Nicolas Martin; Rabi Tawil; Stephen J Tapscott; Baziel G M van Engelen; Vincent Mouly; Gillian S Butler-Browne; Silvère M van der Maarel
Journal:  Am J Pathol       Date:  2012-08-04       Impact factor: 4.307

2.  FSH dystrophy and a subtelomeric 4q haplotype: a new assay and associations with disease.

Authors:  K Tsumagari; D Chen; J R Hackman; A D Bossler; M Ehrlich
Journal:  J Med Genet       Date:  2010-08-15       Impact factor: 6.318

3.  CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.

Authors:  Autumn Rieken; Aaron D Bossler; Katherine D Mathews; Steven A Moore
Journal:  Neurology       Date:  2020-12-21       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.